Clinical Trials

Uterine Fibroid Study

Posted on 7/25/2017

The purpose of this study is to test how effective and safe the investigational study drug, given with and without FDA approved low-dose estradiol (estrogen) and norethindrone (progesterone) is in treating uterine fibroids and heavy menstrual bleeding.  The low dose estrogen and progesterone medication has been approved by the FDA as hormone replacement therapy to prevent bone loss. The use of the FDA approved low-dose estradiol and norethindrone used with the study drug to treat patients with heavy menstrual bleeding associated with uterine fibroids is investigational.

We want to find out if the study drug has an effect on the monthly menstrual blood loss, and pain associated with uterine fibroids as well as any effect on the size of the fibroids.

You may qualify if you:

  • have heavier than normal bleeding during your menstrual period
  • have been diagnosed with uterine fibroids or suspect uterine fibroids
  • are a premenopausal female aged 18 - 50 (inclusive)
If you qualify and complete all visits, you may receive up to $1,150 compensation for your time and travel while in the study.

Call for more information and to see if you qualify for a screening visit.  When you call, ask to speak to Kim.
What Our Research Patients are Saying
Everyone at DCOL Research is friendly and helpful. They all have a great sense of humor, which really helps you relax.  I have participated in several studies with them and the research coordinator I see is awesome. She makes you feel that your health is her top priority.  The research doctor is really good too and if you start having problems during the study he will take care of you. This research clinic is like a family, and once you participate in a study, you are just part of the family.     R. O.

Contact Form

DCOL of Longview